Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125667911 | 12566791 | 1 | I | 20160307 | 20160712 | 20160718 | 20160718 | EXP | GB-MHRA-EYC 00142118 | GB-ELI_LILLY_AND_COMPANY-GB201607004428 | ELI LILLY AND CO | 32.00 | YR | M | Y | 92.00000 | KG | 20160718 | CN | GB | GB |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125667911 | 12566791 | 1 | PS | DULOXETINE HYDROCHLORIDE. | DULOXETINE HYDROCHLORIDE | 1 | Oral | 60 MG, UNKNOWN | Y | U | 21427 | 60 | MG | ||||||
125667911 | 12566791 | 2 | C | DIHYDROCODEINE BITARTRATE | DIHYDROCODEINE BITARTRATE | 1 | UNK | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125667911 | 12566791 | 1 | Borderline personality disorder |
125667911 | 12566791 | 2 | Facial pain |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125667911 | 12566791 | OT |
125667911 | 12566791 | HO |
125667911 | 12566791 | DS |
125667911 | 12566791 | LT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125667911 | 12566791 | Abdominal pain upper | |
125667911 | 12566791 | Abnormal dreams | |
125667911 | 12566791 | Affect lability | |
125667911 | 12566791 | Aggression | |
125667911 | 12566791 | Agitation | |
125667911 | 12566791 | Alcohol intolerance | |
125667911 | 12566791 | Alcoholism | |
125667911 | 12566791 | Anxiety disorder | |
125667911 | 12566791 | Aphonia | |
125667911 | 12566791 | Blood bilirubin increased | |
125667911 | 12566791 | Chromaturia | |
125667911 | 12566791 | Confusional state | |
125667911 | 12566791 | Cough | |
125667911 | 12566791 | Crying | |
125667911 | 12566791 | Disturbance in attention | |
125667911 | 12566791 | Dry mouth | |
125667911 | 12566791 | Dysphonia | |
125667911 | 12566791 | Epistaxis | |
125667911 | 12566791 | Faeces pale | |
125667911 | 12566791 | Fatigue | |
125667911 | 12566791 | General physical health deterioration | |
125667911 | 12566791 | Gingival bleeding | |
125667911 | 12566791 | Headache | |
125667911 | 12566791 | Hyperhidrosis | |
125667911 | 12566791 | Hypnagogic hallucination | |
125667911 | 12566791 | Hypomania | |
125667911 | 12566791 | Impatience | |
125667911 | 12566791 | Impulsive behaviour | |
125667911 | 12566791 | Insomnia | |
125667911 | 12566791 | Intention tremor | |
125667911 | 12566791 | Jaundice | |
125667911 | 12566791 | Logorrhoea | |
125667911 | 12566791 | Loss of libido | |
125667911 | 12566791 | Mania | |
125667911 | 12566791 | Mental fatigue | |
125667911 | 12566791 | Micropenis | |
125667911 | 12566791 | Nasal dryness | |
125667911 | 12566791 | Off label use | |
125667911 | 12566791 | Pain in extremity | |
125667911 | 12566791 | Paraesthesia | |
125667911 | 12566791 | Parotid gland enlargement | |
125667911 | 12566791 | Peripheral swelling | |
125667911 | 12566791 | Personality change | |
125667911 | 12566791 | Salivary hypersecretion | |
125667911 | 12566791 | Suicidal ideation | |
125667911 | 12566791 | Tremor | |
125667911 | 12566791 | Urine odour abnormal | |
125667911 | 12566791 | Vomiting | |
125667911 | 12566791 | Vomiting projectile | |
125667911 | 12566791 | Withdrawal syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125667911 | 12566791 | 1 | 20160301 | 20160601 | 0 | |
125667911 | 12566791 | 2 | 20060101 | 0 |